Company Announcement Phosphagenics Initiates Oxycodone Patch Dosing in Phase 2 Clinical Trial April 17, 2015
Company Announcement Phosphagenics signs license agreement to expand TPM®-based animal nutrition products to the UK and Ireland March 25, 2015
Company Announcement Phosphagenics Decides to put its BioElixia Cosmetics Brand up for Sale February 25, 2015
Company Announcement Phosphagenics Appoints Dr Ross Murdoch as Chief Executive Officer January 14, 2015
Company Announcement Phosphagenics Announces Successful Results from its Phase 2 TPM®/Tretinoin Gel Study on Acne Patients October 7, 2014